Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Apr 2023 for TherapeuticsMD, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael C. Donegan: trading record in brief
Michael C. Donegan, listed as finance chief, appears in our data through filings on TherapeuticsMD, Inc. shares, published by SEC (Form 4). Between 10 May 2021 and 12 April 2023, the trades on record add up to 6 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 14 April 2023, reports an option exercise in TherapeuticsMD, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael C. Donegan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
50,000 shares0Common StockSEC:0001209191-23-024386:0
2,400 shares0Common StockSEC:0001209191-23-005554:0
380 shares0Common StockSEC:0001209191-23-004871:0
2,300 shares0Common StockSEC:0001209191-22-060585:0
115,000 sharesCommon StockSEC:0001209191-21-067391:0
19,000 sharesCommon StockSEC:0001387131-21-005571:0
6 of 6 declarations
